Supplemental Tables S1-4 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin,Anand Mayakonda,Huy Q. Dinh,Pinbo Huang,Lehang Lin,Xiaoping Liu,Ling-wen Ding,Jie Wang,Benjamin P. Berman,Er-Wei Song,Dong Yin,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.22416153

2023-01-01

Abstract:Files containing sequencing details and sample information

What problem does this paper attempt to address?

Supplemental Table S5 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin,Anand Mayakonda,Huy Q. Dinh,Pinbo Huang,Lehang Lin,Xiaoping Liu,Ling-wen Ding,Jie Wang,Benjamin P. Berman,Er-Wei Song,Dong Yin,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.22416159

2023-01-01

Abstract:File containing all somatic mutations
Supplemental Table S6-9 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin,Anand Mayakonda,Huy Q. Dinh,Pinbo Huang,Lehang Lin,Xiaoping Liu,Ling-wen Ding,Jie Wang,Benjamin P. Berman,Er-Wei Song,Dong Yin,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.22416156

2023-01-01

Abstract:Files containing results related to methylation ITH
Supplementary Information from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin,Anand Mayakonda,Huy Q. Dinh,Pinbo Huang,Lehang Lin,Xiaoping Liu,Ling-wen Ding,Jie Wang,Benjamin P. Berman,Er-Wei Song,Dong Yin,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.22416144.v1

2023-01-01

Abstract:File containing Supplementary methods and figure legends
Supplementary Fig.1-11 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin,Anand Mayakonda,Huy Q. Dinh,Pinbo Huang,Lehang Lin,Xiaoping Liu,Ling-wen Ding,Jie Wang,Benjamin P. Berman,Er-Wei Song,Dong Yin,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.22416150.v1

2023-01-01

Abstract:Files containing resutls related to genomic and methylation ITH , detailed mutational signatures, and sample pathology
Supplementary Figures and Tables from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Arvind S. Mer,Wail Ba-Alawi,Petr Smirnov,Yi X. Wang,Ben Brew,Janosch Ortmann,Ming-Sound Tsao,David W. Cescon,Anna Goldenberg,Benjamin Haibe-Kains

DOI: https://doi.org/10.1158/0008-5472.22421108

2023-01-01

Abstract:Supplementary figures and tables
Supplementary Data File 1 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Arvind S. Mer,Wail Ba-Alawi,Petr Smirnov,Yi X. Wang,Ben Brew,Janosch Ortmann,Ming-Sound Tsao,David W. Cescon,Anna Goldenberg,Benjamin Haibe-Kains

DOI: https://doi.org/10.1158/0008-5472.22421126.v1

2023-01-01

Abstract:Time vs. tumor volume plots for all 4,483 PDXs from PDXE dataset, generated using Xeva function plotPDX.
Data from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin,Anand Mayakonda,Huy Q. Dinh,Pinbo Huang,Lehang Lin,Xiaoping Liu,Ling-wen Ding,Jie Wang,Benjamin P. Berman,Er-Wei Song,Dong Yin,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.c.6509472

2023-01-01

Abstract:<div>AbstractUnderstanding the intratumoral heterogeneity of hepatocellular carcinoma is instructive for developing personalized therapy and identifying molecular biomarkers. Here we applied whole-exome sequencing to 69 samples from 11 patients to resolve the genetic architecture of subclonal diversification. Spatial genomic diversity was found in all 11 hepatocellular carcinoma cases, with 29% of driver mutations being heterogeneous, including TERT, ARID1A, NOTCH2, and STAG2. Similar with other cancer types, TP53 mutations were always shared between all tumor regions, that is, located on the “trunk” of the evolutionary tree. In addition, we found that variants within several drug targets such as KIT, SYK, and PIK3CA were mutated in a fully clonal manner, indicating their therapeutic potentials for hepatocellular carcinoma. Temporal dissection of mutational signatures suggested that mutagenic processes associated with exposure to aristolochic acid and aflatoxin might play a more important role in early, as opposed to late, stages of hepatocellular carcinoma development. Moreover, we observed extensive intratumoral epigenetic heterogeneity in hepatocellular carcinoma based on multiple independent analytical methods and showed that intratumoral methylation heterogeneity might play important roles in the biology of hepatocellular carcinoma cells. Our results also demonstrated prominent heterogeneity of intratumoral methylation even in a stable hepatocellular carcinoma genome. Together, these findings highlight widespread intratumoral heterogeneity at both the genomic and epigenomic levels in hepatocellular carcinoma and provide an important molecular foundation for better understanding the pathogenesis of this malignancy. Cancer Res; 77(9); 2255–65. ©2017 AACR.</div>
Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Yun Liu,Xinran Zhang,Baicai Yang,Hao Zhuang,Hua Guo,Wen Wei,Yuan Li,Ruibing Chen,Yongmei Li,Ning Zhang

DOI: https://doi.org/10.1158/0008-5472.22418658

2023-01-01

Abstract:This file contains all Supplemental tables that including clinicopathological information of HCC tissue samples and sequences of DNA primer, siRNAs, and shRNAs.
Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133+ Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Lixing Zhang,Hefen Sun,Fangyu Zhao,Peixiang Lu,Ge Chen,Hong Li,Helei Hou,Mingxia Yan,Taoyang Chen,Guoping Jiang,Haiyang Xie,Ying Cui,Xiaowu Huang,Jia Fan,Ming Yao,Jinjun Li

DOI: https://doi.org/10.1158/0008-5472.22395141

2023-01-01

Abstract:PDF file - 47K, Sequences of primers used in this study
Supplementary Table 1 from An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer

Qing-Wen Xu,Wei Zhao,Yue Wang,Maureen A. Sartor,Dong-Mei Han,Jixin Deng,Rakesh Ponnala,Jiang-Ying Yang,Qing-Yun Zhang,Guo-Qing Liao,Yi-Mei Qu,Lu Li,Fang-Fang Liu,Hong-Mei Zhao,Yan-Hui Yin,Wei-Feng Chen,Yu Zhang,Xiao-Song Wang

DOI: https://doi.org/10.1158/0008-5472.22394709

2023-01-01

Abstract:PDF file - 66K, Detailed information for the adult somatic tissues and cancer tissues from the five Affymetrix U133 plus2 gene expression datasets compiled for HEPA analysis
Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma

Youpei Lin,Lihua Peng,Liangqing Dong,Dongbing Liu,Jiaqiang Ma,Jian Lin,Xiaofang Chen,Penghui Lin,Guohe Song,Mao Zhang,Yuming Liu,Junhua Rao,Chen Wei,Ye Lu,Shu Zhang,Guangyu Ding,Zhenyu Peng,Haorong Lu,Xiaoying Wang,Jian Zhou,Jia Fan,Kui Wu,Qiang Gao

DOI: https://doi.org/10.1158/2159-8290.22542075.v1

2023-01-01

Abstract:Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Supplementary Tables S1-S9 from Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients

Tingting Yan,Linlin Lu,Conghua Xie,Jiamei Chen,Xiaojuan Peng,Liehuang Zhu,Ying Wang,Qiang Li,Jing Shi,Fuyuan Zhou,Ming Hu,Zhongqiu Liu

DOI: https://doi.org/10.1158/1535-7163.22503685.v1

2023-01-01

Abstract:The supplementary data contain Supplementary Tables S1 to S9. Supplementary Table S1. Human Liver Donor Details and Tissue Histology Supplementary Table S2. Incubation Conditions for CYP Activity Assays Supplementary Table S3. Analytical Parameters for Activity Assays of CYPs. Supplementary Table S4. Sequences and MRM Transitions of Proteotypic Peptides for Quantifying CYP Enzymes Supplementary Table S5. Oligonucleotide PCR Primers for Human CYP Enzymes and GAPDH Supplementary Table S6. Summary of Enzyme Kinetic Parameters for Seven CYP Activities in Pooled Human Liver Microsomes. Supplementary Table S7. Summary of Seven CYP Enzymes Activities in Tumor Tissues and Pericarcinomatous Tissues of Patients with HCC Supplementary Table S8. Summary of Seven CYPs Protein Expression Levels in Tumor Tissues and Pericarcinomatous Tissues of Patients with HCC Supplementary Table S9. Summary of Seven CYPs mRNA Expression Levels in Tumor Tissues and Pericarcinomatous Tissues of Patients with HCC
Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934664.v1

2024-01-01

Abstract:Supplementary tables of the revised manuscript.
Supplementary Tables from A Feedback Circuitry Between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis

Kun Liu,Shuye Deng,Xu Li,Wei Pan,Shiyu Yang,Fufu Zheng,Xingui Wu,Hongrong Hu,Zhijun Liu,Junhang Luo,Rui Zhang,Dong‐Ming Kuang,Jiajun Dong,Yi Wu,Hui Zhang,Penghui Zhou,Jin‐Xin Bei,Yang Xu,Jianping Yin,Peng Wang,Huai‐Qiang Ju,Rui‐Hua Xu,Bo Li

DOI: https://doi.org/10.1158/0008-5472.22425276

2023-01-01

Abstract:Supplementary tables S1-S4 show analytic details of the ENCODE ChIP-Seq data and TCGA RNA-Seq data, together with primer sequences used in this study.
Supplementary Table 1 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Genee Y. Lee,Peter M. Haverty,Li Li,Noelyn M. Kljavin,Richard Bourgon,James Lee,Howard Stern,Zora Modrusan,Somasekar Seshagiri,Zemin Zhang,David Davis,David Stokoe,Jeffrey Settleman,Frederic J. de Sauvage,Richard M. Neve

DOI: https://doi.org/10.1158/0008-5472.22399142.v1

2023-01-01

Abstract:XLSX file - 37K, Details of the tumour samples use in the article.
Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Genee Y. Lee,Peter M. Haverty,Li Li,Noelyn M. Kljavin,Richard Bourgon,James Lee,Howard Stern,Zora Modrusan,Somasekar Seshagiri,Zemin Zhang,David Davis,David Stokoe,Jeffrey Settleman,Frederic J. de Sauvage,Richard M. Neve

DOI: https://doi.org/10.1158/0008-5472.22399124

2023-01-01

Abstract:XLSX file - 37K, Supplementary materials and methods (cell lines, STR profiles, primers, antibodies, molecular reagents).
Supplementary Tables 1-2, Figures 1-3 from Variations in HSPA1B at 6p21.3 Are Associated with Lung Cancer Risk and Prognosis in Chinese Populations

Huan Guo,Qifei Deng,Chen Wu,Lingmin Hu,Sheng Wei,Ping Xu,Dan Kuang,Li Liu,Zhibin Hu,Xiaoping Miao,Hongbing Shen,Dongxin Lin,Tangchun Wu

DOI: https://doi.org/10.1158/0008-5472.22390799

2023-01-01

Abstract:PDf file - 549K
Supplementary table 4 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer

Nan Hu,Mitsutaka Kadota,Huaitian Liu,Christian C. Abnet,Hua Su,Hailong Wu,Neal D. Freedman,Howard H. Yang,Chaoyu Wang,Chunhua Yan,Lemin Wang,Sheryl Gere,Amy Hutchinson,Guohong Song,Yuan Wang,Ti Ding,You-Lin Qiao,Jill Koshiol,Sanford M. Dawsey,Carol Giffen,Alisa M. Goldstein,Philip R. Taylor,Maxwell P. Lee

DOI: https://doi.org/10.1158/0008-5472.22410542

2023-01-01

Abstract:Somatic mutations validated by Sanger sequencing
Supplementary Table 2 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer

Nan Hu,Mitsutaka Kadota,Huaitian Liu,Christian C. Abnet,Hua Su,Hailong Wu,Neal D. Freedman,Howard H. Yang,Chaoyu Wang,Chunhua Yan,Lemin Wang,Sheryl Gere,Amy Hutchinson,Guohong Song,Yuan Wang,Ti Ding,You-Lin Qiao,Jill Koshiol,Sanford M. Dawsey,Carol Giffen,Alisa M. Goldstein,Philip R. Taylor,Maxwell P. Lee

DOI: https://doi.org/10.1158/0008-5472.22410551

2023-01-01

Abstract:Summary of the WGS mapping data
Additional File 4 of Clonal Evolution in Liver Cancer at Single-Cell and Single-Variant Resolution

Xianbin Su,Linan Zhao,Yi Shi,Rui Zhang,Qi Long,Shihao Bai,Qing Luo,Yingxin Lin,Xin Zou,Shila Ghazanfar,Kun Tao,Guoliang Yang,Lan Wang,Kunyan He,Xiaofang Cui,Jian He,Jiaoxiang Wu,Bo Han,Bin Yan,Biao Deng,Na Wang,Xin Li,Pengyi Yang,Shangwei Hou,Jingyong Sun,Jean Yee Hwa Yang,Jinhong Chen,Ze‐Guang Han

DOI: https://doi.org/10.6084/m9.figshare.13698268

2021-01-01

Abstract:Additional file 4: Table S2. Mutation sites and amplification primers for single-cell target sequencing. This table shows the full list of target sites and PCR primers used in single-cell target amplification for HCC1, HCC2, HCC9 and HCC8. The primer sequences include the adaptor sequences that can be used for downstream library preparation with illumina Nextera XT Index Kit and multi-plexed sequencing.

Supplemental Tables S1-4 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplemental Table S5 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplemental Table S6-9 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplementary Information from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplementary Fig.1-11 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplementary Figures and Tables from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Data File 1 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Data from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133<sup>+</sup> Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Table 1 from An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer

Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma

Supplementary Tables S1-S9 from Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients

Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Tables from A Feedback Circuitry Between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis

Supplementary Table 1 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Tables 1-2, Figures 1-3 from Variations in <i>HSPA1B</i> at 6p21.3 Are Associated with Lung Cancer Risk and Prognosis in Chinese Populations

Supplementary table 4 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer

Supplementary Table 2 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer

Additional File 4 of Clonal Evolution in Liver Cancer at Single-Cell and Single-Variant Resolution

Supplemental Tables S1-4 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplemental Table S5 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplemental Table S6-9 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplementary Information from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplementary Fig.1-11 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplementary Figures and Tables from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Supplementary Data File 1 from Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Data from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Supplemental Tables from Demethylation-Induced Overexpression of Shc3 Drives c-Raf–Independent Activation of MEK/ERK in HCC

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133&lt;sup&gt;+&lt;/sup&gt; Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Table 1 from An Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens as Potential Immunologic and Clinical Targets in Cancer

Supplementary Table from Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma

Supplementary Tables S1-S9 from Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients

Supplementary Tables 1-5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Tables from A Feedback Circuitry Between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis

Supplementary Table 1 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Table 7 from Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes

Supplementary Tables 1-2, Figures 1-3 from Variations in &lt;i&gt;HSPA1B&lt;/i&gt; at 6p21.3 Are Associated with Lung Cancer Risk and Prognosis in Chinese Populations

Supplementary table 4 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer

Supplementary Table 2 from Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer

Additional File 4 of Clonal Evolution in Liver Cancer at Single-Cell and Single-Variant Resolution

Supplementary Table 2 from BMP4 Administration Induces Differentiation of CD133<sup>+</sup> Hepatic Cancer Stem Cells, Blocking Their Contributions to Hepatocellular Carcinoma

Supplementary Tables 1-2, Figures 1-3 from Variations in <i>HSPA1B</i> at 6p21.3 Are Associated with Lung Cancer Risk and Prognosis in Chinese Populations